Financhill
Back

NewAmsterdam Pharma Co NV 10K Form

Buy
82

NAMS
NewAmsterdam Pharma Co NV

Last Price:
25.55
Seasonality Move:
50.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NAMS News And Ratings

See the #1 stock for the next 7 days that we like better than NAMS

NAMS Financial Statistics

Sales & Book Value

Annual Sales: $14.09M
Cash Flow: $-12.58M
Price / Cash Flow: 0
Annual Sales: $4.11
Price / Book: 6.39

Profitability

EPS (TTM): -2.25000
Net Income (TTM): $-198.92M
Gross Margin: --
Return on Equity: -51.66%
Return on Assets: -46.22%

NewAmsterdam Pharma Co NV Earnings Forecast

Key NewAmsterdam Pharma Co NV Financial Ratios

  • The Research & Development expenses have been 1,131.47% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of NAMS is -1,255.76% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

NewAmsterdam Pharma Co NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NAMS
Website: newamsterdampharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.61
Quick Ratio: 10.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NAMS Technical Analysis vs Fundamental Analysis

Buy
82
NewAmsterdam Pharma Co NV (NAMS) is a Buy

Is NewAmsterdam Pharma Co NV a Buy or a Sell?